Neill A. Giese

Learn More
Targeted therapy with imatinib in chronic myeloid leukemia (CML) prompted a new treatment paradigm. Unlike CML, chronic lymphocytic leukemia (CLL) lacks an aberrant fusion protein kinase but instead(More)
Glioblastoma multiforme, the most common form of malignant brain tumor,is resistant to all forms of therapy and causes death within 9-12 months of diagnosis. Glioblastomas are known to contain(More)
Glioblastoma multiforme, the most common form of malignant brain tumor, is resistant to all forms of therapy and causes death within 9–12 months of diagnosis. Glioblastomas are known to contain(More)